Importantly, the clinically used DMD drug prednisone has been shown to improve movement, strength, and mitochondrial structure in this model, confirming the utility of dys-1(eg33) worms as a DMD drug-screening platform (19, 22). This evidence concerns the gene DMD and Duchenne muscular dystrophy.